amlodipine/valsartan/hydrochlorothiazide (generic Exforge HCT) — United Healthcare
hypertension
Preferred products
- amlodipine/valsartan (generic Exforge)
- hydrochlorothiazide
Initial criteria
- Patient has a history of a trial resulting in therapeutic failure (blood pressure goal not met) to both of the following taken concomitantly: amlodipine/valsartan (generic Exforge) AND hydrochlorothiazide
- Patient is unable to adhere to antihypertensive therapy AND prescriber determines combination therapy would be beneficial
Reauthorization criteria
- Documentation of positive clinical response to therapy
Approval duration
12 months